亨廷顿病LIG1修饰器变体增加了连接酶的忠实性,并抑制了体质CAG重复扩张
Eunhye Lee1,2, Wonju Kim1,2, David H Beier3
1Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
bioRxiv : the preprint server for biology
|August 12, 2025
概括
一种DNA连接酶1 (LIG1) 变体通过提高DNA修复效率来延迟亨廷顿病 (HD) 的发病. 这种变异减缓了亨廷顿病基因 (HTT) 的体扩张,并保护了基因组,为HD提供了一个新的治疗点.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 亨廷顿病 (HD) 是一种致命的神经退行性疾病,与亨廷丁基因 (HTT) 中扩大的CAG重复有关.
- 这些重复的体质扩张有助于疾病的进展.
- 全基因组关联研究确定了影响HD发病和进展的修饰基因.
研究的目的:
- 为了研究与延迟HD发病相关的特定DNA连接酶1 (LIG1) 变体 (K845N) 的保护机制.
- 了解LIG1 K845N如何影响DNA修复忠实度和体扩张.
- 探索LIG1 K845N作为HD的潜在治疗点.
主要方法:
- 在体外结合酶试验和酶动力学以评估LIG1 K845N活性.
- 基于细胞的测试来评估对氧化应激的保护.
- 用LIG1 K843N正义仪对HD试验小鼠体内CAG扩张进行分析.
主要成果:
- 这种LIG1 K845N变异增强了对不匹配基质的歧视,增加了DNA修复保真度.
- 在细胞模型中,K845N 提供了对氧化应激的保护.
- 鼠标LIG1 K843N正方体显著抑制了HD敲进小鼠体质CAG扩张.
结论:
- 由于K845N替代而改变的DNA结合酶1功能可能会通过减少大脑体扩张来延迟HD的临床发病.
- 增加的DNA连接酶忠实性提供了对基因组损伤的保护.
- DNA连接酶忠实性为亨廷顿病和其他重复扩张障碍提供了一个有前途的治疗标.
更多相关视频
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
2.6K
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
8.1K
相关概念视频
Hedgehog Signaling Pathway
7.5K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.5K
Covalently Linked Protein Regulators
7.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.2K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Protein Complexes with Interchangeable Parts
2.6K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K
